EY
EYE.CD
—
—
Medical Equipment, Supplies & Distribution
Rise Nano Optics Ltd
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
—
ROE
—
Net margin
—
Debt / equity
—
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About
Rise Nano Optics Ltd develops and commercializes nanophotonic solutions for ophthalmic and medical imaging applications.
Business. Rise Nano Optics Ltd (EYE.CD) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not provided in the available data.
Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership→
American Century Investment Management, Inc.
largest disclosed fund holder
Profitability
—
not yet wired
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to EYE.CD. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
Rise Nano Optics Ltd (EYE.CD) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not provided in the available data.
Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
AI synthesis
GENERATED— missing data
Key takeaways
- The company's capital structure shows no immediate dilution risk, with basic and diluted shares outstanding being equal.
- Liquidity risk cannot be assessed due to missing balance-sheet data and lack of going-concern disclosures.
- Profitability metrics are unavailable, preventing comparison to industry benchmarks for medical equipment firms.
- Segment and geographic exposure data are not disclosed, limiting visibility into revenue concentration and diversification.
- Growth trajectory data is incomplete, with no numeric deltas provided for current or next fiscal years.
- Risk factors include unassessable liquidity risk and limited financial transparency.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation
Market price
$0,70
Market cap
—
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
—
Net cashⓘ
—
Current ratioⓘ
—
Debt / equityⓘ
—
ROAⓘ
—
ROEⓘ
—
Cash conversionⓘ
—
CapEx / revenueⓘ
—
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
Business relationships9 disclosed relationships · 2 types · extracted from filings & disclosures
Partners1
Walmart IncWMT.OPartner95%Source ↗
Subsidiaries8
EX21:11d410bc6946EX21:11d410bc6946Subsidiarie97%
EX21:182ed95f518bEX21:182ed95f518bSubsidiarie97%
EX21:1b89db76ac2fEX21:1b89db76ac2fSubsidiarie97%
EX21:2b4ce5948c05EX21:2b4ce5948c05Subsidiarie97%
EX21:c29c17f60ad9EX21:c29c17f60ad9Subsidiarie97%
EX21:cf2f47586901EX21:cf2f47586901Subsidiarie97%
EX21:d27274dedce0EX21:d27274dedce0Subsidiarie97%
EX21:d3e634d7f1bbEX21:d3e634d7f1bbSubsidiarie97%
Supply chain
Vendors → EYE ↔ Partners → Customers · click any node to drill
1 mention in 10-K0 from corporate websites0 from news dispatches
Updated 2026-06-24Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
— missing data
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskUnknown
Benchmarks vs cohort
No cohort benchmark data available for this issuer yet.
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
Derivative transactions
Net acquired 27 553 sh14 exercises · 10 grants10 insiders
- Director, Chief Executive Officer · Restricted Stock Units → Common StockDisposed 13 768exercise · 2026-07-31
- President, America's Best · Restricted Stock Units → Common StockDisposed 11 728exercise · 2026-07-08
- Chief Legal & Strategy Officer · Restricted Stock Units → Common StockDisposed 1 890exercise · 2026-04-29
- Chief Financial Officer · Restricted Stock Units → Common StockDisposed 26 082exercise · 2026-03-31
- Chief Technology Officer · Restricted Stock Units → Common StockAcquired 10 753grant · 2026-03-06
- Director, Executive Chairman · Restricted Stock Units → Common StockAcquired 71 685grant · 2026-03-06
- Director, Executive Chairman · Restricted Stock Units → Common StockDisposed 54 824exercise · 2026-03-06
- Director, Chief Executive Officer · Restricted Stock Units → Common StockAcquired 62 725grant · 2026-03-06
- Director, Chief Executive Officer · Restricted Stock Units → Common StockDisposed 27 412exercise · 2026-03-06
- Chief Financial Officer · Restricted Stock Units → Common StockAcquired 17 922grant · 2026-03-06
- Chief Legal & Strategy Officer · Restricted Stock Units → Common StockAcquired 10 753grant · 2026-03-06
- Chief Legal & Strategy Officer · Restricted Stock Units → Common StockDisposed 10 279exercise · 2026-03-06
- Chief People Officer · Restricted Stock Units → Common StockAcquired 10 753grant · 2026-03-06
- Chief People Officer · Restricted Stock Units → Common StockDisposed 8 224exercise · 2026-03-06
- President, America's Best · Restricted Stock Units → Common StockAcquired 10 753grant · 2026-03-06
- President, America's Best · Restricted Stock Units → Common StockDisposed 13 706exercise · 2026-03-06
- Chief Brand & Mktg Officer · Restricted Stock Units → Common StockAcquired 10 753grant · 2026-03-06
- Chief Brand & Mktg Officer · Restricted Stock Units → Common StockDisposed 8 224exercise · 2026-03-06
- Head of Emerging Brands · Restricted Stock Units → Common StockAcquired 10 753grant · 2026-03-06
- Head of Emerging Brands · Restricted Stock Units → Common StockDisposed 8 224exercise · 2026-03-06
- SVP, CHIEF MERCH. & MC OFFICER · Restricted Stock Units → Common StockAcquired 10 753grant · 2026-03-06
- Head of Emerging Brands · Restricted Stock Units → Common StockDisposed 2 989exercise · 2026-03-03
- Chief Brand & Mktg Officer · Restricted Stock Units → Common StockDisposed 6 350exercise · 2026-03-03
- SVP, Chief People Officer · Restricted Stock Units → Common StockDisposed 6 350exercise · 2026-03-03
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Source documents
- Rise Nano Optics Ltd Market data — financials · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,04 %$84M
- Investment Managers · as of 2026-03-310,03 %$62M
- Investment Managers · as of 2026-03-310,03 %$47M
- Institutional Investor · as of 2022-09-300,03 %$0M
- Investment Managers · as of 2026-03-310,03 %$142M
- Investment Managers · as of 2026-03-310,02 %$64M
- Investment Managers · as of 2026-03-310,02 %$79M
- Investment Managers · as of 2026-03-310,01 %$20M
- Institutional Investor · as of 2026-03-310,01 %$34M
- Investment Managers · as of 2026-03-310,01 %$10M
- Investment Managers · as of 2026-03-310,01 %$34M
- Funds · as of 2026-03-310,00 %$31M
- Investment Managers · as of 2025-12-310,00 %$273M
- Investment Managers · as of 2026-03-310,00 %$22M
- Investment Managers · as of 2026-03-310,00 %$57M
- Investment Managers · as of 2026-03-310,00 %$26M
- Investment Managers · as of 2026-03-310,00 %$22M
- Investment Managers · as of 2026-03-310,00 %$82M
- Investment Managers · as of 2026-03-310,00 %$6M
- Institutional Investor · as of 2026-03-310,00 %$12M
- Investment Managers · as of 2026-03-310,00 %$31M
- Institutional Investor · as of 2026-03-310,00 %$28M
- Investment Managers · as of 2024-12-310,00 %$3M
- Brokerage Firms · as of 2026-03-310,00 %$3M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
Net selling1 buys · 3 sellsnet -$498K16 insiders · last 365d
- Director, Chief Executive Officer · Common StockOther 13 768 · 2026-07-31
- Director, Chief Executive Officer · Common StockOther 6 660 @ $22,04$147K · 2026-07-31
- President, America's Best · Common StockOther 4 964 @ $19,41$96K · 2026-07-08
- President, America's Best · Common StockOther 11 728 · 2026-07-08
- Director · Common StockOther 11 350 · 2026-06-17
- Director · Common StockOther 16 258 · 2026-06-17
- Director · Common StockOther 16 258 · 2026-06-17
- Director · Common StockOther 14 571 · 2026-06-17
- Director · Common StockOther 11 350 · 2026-06-17
- Director · Common StockOther 11 350 · 2026-06-17
- Director · Common StockOther 11 350 · 2026-06-17
- Director · Common StockOther 11 350 · 2026-06-17
- Director · Common StockBought 50 000 @ $15,52$776K · 2026-06-05
- Chief Legal & Strategy Officer · Common StockOther 842 @ $22,39$19K · 2026-04-29
- Chief Legal & Strategy Officer · Common StockOther 1 890 · 2026-04-29
- Chief Financial Officer · Common StockOther 26 082 · 2026-03-31
- Chief Financial Officer · Common StockOther 9 702 @ $25,90$251K · 2026-03-31
- Director, Chief Executive Officer · Common StockSold 35 000 @ $26,54$929K · 2026-03-11
- Director, Executive Chairman · Common StockSold 7 601 @ $29,58$225K · 2026-03-06
- Head of Emerging Brands · Common StockOther 8 224 · 2026-03-06
- Head of Emerging Brands · Common StockOther 2 738 @ $27,90$76K · 2026-03-06
- Chief Brand & Mktg Officer · Common StockOther 8 224 · 2026-03-06
- Chief Brand & Mktg Officer · Common StockOther 2 430 @ $27,90$68K · 2026-03-06
- Director, Executive Chairman · Common StockSold 4 071 @ $29,57$120K · 2026-03-06
- President, America's Best · Common StockOther 13 706 · 2026-03-06
Short positioning
16.6Mshares short+0.5% vs prior
8.95days to cover
50.6%short of daily vol
1.5Kfails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
EYE.CDCanonical
— · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskUnknown
Relationship graph
This companySectorPartnersSubsidiaries
Evidence & claims
From filings & derived data- Revenue (YoY) (2026-01-03 vs 2024-12-28): 9.0%Derived (calculated)
- Shareholders' equity (YoY) (2026-01-03 vs 2024-12-28): 6.5%Derived (calculated)
- Total assets (YoY) (2026-01-03 vs 2024-12-28): -1.2%Derived (calculated)
- Long-term debt (YoY) (2026-01-03 vs 2024-12-28): -29.9%Derived (calculated)
- Capex (YoY) (2026-01-03 vs 2024-12-28): -23.7%Derived (calculated)
- Net margin (FY 2026-01-03): 1.5%Derived (calculated)
- Return on equity (FY 2026-01-03): 3.4%Derived (calculated)
- Return on assets (FY 2026-01-03): 1.5%Derived (calculated)
- Current ratio (FY 2026-01-03): 0.55xDerived (calculated)
- EPS (basic) (YoY) (2026-01-03 vs 2024-12-28): 202.8%Derived (calculated)
- EPS (diluted) (YoY) (2026-01-03 vs 2024-12-28): 202.8%Derived (calculated)
- Cash & equivalents (YoY) (2026-01-03 vs 2024-12-28): -47.7%Derived (calculated)
- Operating cash flow (YoY) (2026-01-03 vs 2024-12-28): 9.5%Derived (calculated)
- Net income (YoY) (2026-01-03 vs 2024-12-28): 203.9%Derived (calculated)
- Operating income (YoY) (2026-01-03 vs 2024-12-28): 667.9%Derived (calculated)
- Operating income (annual): USD 58.83MSEC XBRL filing
- Cash & equivalents (annual): USD 38.71MSEC XBRL filing
- Shareholders' equity (annual): USD 869.53MSEC XBRL filing
- Capex (annual): USD 72.84MSEC XBRL filing
- Total assets (annual): USD 1.98BSEC XBRL filing
- Pre-tax income (annual): USD 41.68MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 0SEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES 0SEC XBRL filing
- Net income (annual): USD 29.6MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
2026-07-08INSIDERBanner Mark transacted 5.0k sh — President, America's Best ~$96k
2026-07-08INSIDERBanner Mark transacted 11.7k sh — President, America's Best
2026-07-08INSIDERBanner Mark disposed of 11.7k sh Restricted Stock Units — President, America's Best
2026-06-17 00:00 UTCINSIDER9 insider transactions — 2026-06 · net buy $776k
2026-06-17INSIDERKelman Naomi transacted 11.3k sh — Director
2026-06-17INSIDERZulla Caitlin transacted 16.3k sh — Director
2026-06-17INSIDEROFarrell Susan C transacted 14.6k sh — Director
2026-06-17INSIDERNicholson Michael J transacted 11.3k sh — Director
2026-06-17INSIDERMcGrann James M. transacted 11.3k sh — Director
2026-06-17INSIDERJohnson Susan S transacted 11.3k sh — Director
2026-06-17INSIDERHepner Virginia A transacted 11.3k sh — Director
2026-06-17INSIDERArmario Jose transacted 16.3k sh — Director
2026-06-05INSIDERNicholson Michael J bought 50.0k sh — Director ~$776k
2026-04-29 00:00 UTCINSIDER3 insider transactions — 2026-04 1 derivative
2026-04-29INSIDERBrandman Jared transacted 1.9k sh — Chief Legal & Strategy Officer
2026-04-29INSIDERBrandman Jared transacted 842 sh — Chief Legal & Strategy Officer ~$19k
2026-04-29INSIDERBrandman Jared disposed of 1.9k sh Restricted Stock Units — Chief Legal & Strategy Officer
2026-03-31 00:00 UTCINSIDER52 insider transactions — 2026-03 · net sell $3.7M 21 derivative
2026-03-31INSIDERLaden Christopher transacted 9.7k sh — Chief Financial Officer ~$251k
2026-03-31INSIDERLaden Christopher transacted 26.1k sh — Chief Financial Officer
2026-03-31INSIDERLaden Christopher disposed of 26.1k sh Restricted Stock Units — Chief Financial Officer
2026-03-11INSIDERWilkes Alexander sold 35.0k sh — Director, Chief Executive Officer ~$929k
2026-03-06INSIDERVanDette Joseph transacted 8.2k sh — Chief Brand & Mktg Officer
2026-03-06INSIDERPatel Priti V transacted 8.2k sh — Head of Emerging Brands
2026-03-06INSIDERPatel Priti V transacted 2.7k sh — Head of Emerging Brands ~$76k
2026-03-06INSIDERVanDette Joseph transacted 2.4k sh — Chief Brand & Mktg Officer ~$68k
2026-03-06INSIDERBanner Mark transacted 13.7k sh — President, America's Best
2026-03-06INSIDERBanner Mark transacted 4.1k sh — President, America's Best ~$115k
2026-03-06INSIDERClark Bill transacted 8.2k sh — Chief People Officer
2026-03-06INSIDERClark Bill transacted 2.4k sh — Chief People Officer ~$68k
2026-03-06INSIDERBrandman Jared transacted 10.3k sh — Chief Legal & Strategy Officer
2026-03-06INSIDERVanDette Joseph disposed of 8.2k sh Restricted Stock Units — Chief Brand & Mktg Officer
2026-03-06INSIDERVanDette Joseph acquired 10.8k sh Restricted Stock Units — Chief Brand & Mktg Officer
2026-03-06INSIDERBrandman Jared disposed of 10.3k sh Restricted Stock Units — Chief Legal & Strategy Officer
2026-03-06INSIDERFAHS L READE acquired 71.7k sh Restricted Stock Units — Director, Executive Chairman
Showing the 40 most recent of 56 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage